Clinical Trials Directory

Trials / Completed

CompletedNCT01991444

CGA-TAVI Registry to Evaluate the Predictive Value of a CGA in Predicting TAVI Outcomes

Registry Study to Evaluate the Predictive Value of a Comprehensive Geriatric Assessment With Regard to the Outcome of a Transcatheter Aortic Valve Implantation.

Status
Completed
Phase
Study type
Observational
Enrollment
72 (actual)
Sponsor
Institut für Pharmakologie und Präventive Medizin · Network
Sex
All
Age
80 Years
Healthy volunteers
Not accepted

Summary

Registry study to evaluate the predictive value of a comprehensive geriatric assessment with regard to the outcome of a transcatheter aortic valve Implantation. It will be evaluated which parts of the comprehensive geriatric assessment (CGA) are best suited to predict the therapeutic success of a heart valve Implantation in elderly ( \> 80 years) Patient. Possible participants are all Patient of 80 years or above for whom the implantation of a Edwards Sapien XT aortic valve is planned

Detailed description

Transcatheter Aortic Valve Implantation Registry with Comprehensive Geriatric Assessment

Conditions

Interventions

TypeNameDescription
OTHERTAVIno Intervention planned, Observation only

Timeline

Start date
2014-02-01
Primary completion
2016-12-01
Completion
2017-02-01
First posted
2013-11-25
Last updated
2017-04-05

Locations

3 sites across 3 countries: Canada, Italy, Netherlands

Source: ClinicalTrials.gov record NCT01991444. Inclusion in this directory is not an endorsement.